文献速递血液净化与透析

血液透析中心静脉导管出口部位感染早期检测临床量表的验证

Validation of a Clinical Scale for Early Detection of Infections at the Exit Site of Central Venous Catheters for Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2024-06-28

INTRODUCTION: Exit-site infections (ESI) of central venous catheters for hemodialysis (CVC-HD) has been associated with early catheter removal and an increased risk of CVC-HD related bacteremia. No specific clinical scales to predict ESI have previously been validated.…

要点

  • 最终量表保留透析间期出口处疼痛、出口处≥2 cm充血或红斑、出口处脓肿或脓性渗出3项。
  • 量表ROC曲线下面积88.3%,敏感度80.34%,特异度95.23%,约登指数0.7557。
  • 护士每透析次评估出口部位,任一阳性项即采集导管周围皮肤拭子培养作为金标准。

核心结论

  • 该临床量表对血液透析中心静脉导管出口部位感染具有良好预测性能,可检测约90%的出口部位感染。

主要发现

  • 最终量表包含透析间期出口处疼痛、出口处≥2 cm充血或红斑、出口处脓肿或脓性渗出3项体征。
  • 最终量表ROC曲线下面积88.3%(95%CI:85.2%-91%;P<0.001),约登指数0.7557≈1。
  • 敏感度80.34%(95%CI:71.36%-87.71%),特异度95.23%(95%CI:92.73%-97%)。

关键数值与推荐

  • 初步量表包含5项:透析间期出口处疼痛、出口处≥2 cm充血或红斑、出口处炎症/硬结/肿胀、非其他原因发热≥38°C、出口处明显脓肿或脓性渗出。
  • 最终验证量表保留3项:透析间期出口处疼痛、出口处≥2 cm充血或红斑、出口处脓肿或脓性渗出。
  • 任一量表项阳性时采集导管周围皮肤拭子培养,阳性结果为金标准。
  • 量表验证采用ROC曲线和逻辑回归分析,并应用logit函数计算ESI概率。

临床怎么用

  • 护士可在每次血液透析时使用该3项量表评估导管出口部位,早期识别出口部位感染。
  • 任一量表项阳性时应采集导管周围皮肤拭子培养以辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Exit-site infections (ESI) of central venous catheters for hemodialysis (CVC-HD) has been associated with early catheter removal and an increased risk of CVC-HD related bacteremia. No specific clinical scales to predict ESI have previously been validated. METHODS: A multicenter prospective cohort study was performed to validate the proposed scale, which is based on the following 5 signs and symptoms: (i) pain at exit site during interdialytic period; (ii) hyperemia or erythema ≥2 cm from exit site; (iii) inflammation, induration, or swelling at exit site; (iv) fever ≥38 °C not attributable to other causes, and (v) obvious abscess or purulent exudate at the exit site. Adult patients with a tunneled CVC-HD for at least 1 month after insertion has been included. During each hemodialysis session, the exit site was assessed with the proposed scale by nurses. If any item was present, a pericatheter skin swab culture was collected: positive results were gold standard. The scale was validated using receiver operating characteristic (ROC) curves and logistic regression analysis. For this purpose, the logit function was applied, and the ESI probability calculated, as elogit ESI/1 + elogit ESI. RESULTS: Three hundred thirty-seven CVC-HDs from 310 patients were analyzed, producing 515 cultures (117 infected and 398 healthy). The final version of the scale includes the following 3 signs and symptoms, which present the greatest predictive capacity: (i) pain at exit site during interdialytic period, (ii) hyperemia or erythema ≥2 cm from exit site, and (iii) abscess or purulent exudate at the exit site. The final version generated an area under the ROC curve (AUC) of 88.3% (95% confidence interval [CI]: 85.2%-91%; P < 0.001), Youden index 0.7557 ≈ 1, sensitivity 80.34% (95% CI: 71.36%-87.71%) and specificity 95.23% (95% CI: 92.73%-97%). CONCLUSIONS: The validation shows that the scale has good predictive properties, detecting approximately 90% of ESI with very acceptable validity parameters.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Cobo-Sánchez JL, Blanco-Mavillard I, Pelayo-Alonso R, et al. Validation of a Clinical Scale for Early Detection of Infections at the Exit Site of Central Venous Catheters for Hemodialysis. Kidney Int Rep. 2024. PMID: 39291192. doi:10.1016/j.ekir.2024.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。